Obermatt
See Similar Stocks →

Simulations Plus

NSQ:SLP · US8292141053
Health Care TechnologySmall

360

29
EV / EBIT16
Price / Owner Earnings63
Owner Earnings Yield1
Dividend Yield1
Price/Sales32
EV / Gross Profit34
Price/Book40
Return on Capital77
Cash Return on Capital22
Return on Equity25
EBIT Margin89
Gross Profitability55
Accruals100
Owner Earnings Margin12
Sales growth48
Profit Growth32
Long-Term EPS Growth53
Reinvestment69
Price momentum28
Debt load97
Refinancing73
Debt Payback1
Liquidity1
Analyst ratings38
Opinion Changes50
Price Target Upside57
Market mood71
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Simulations Plus clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Technology
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded1996
Employees152
Websitesimulations-plus.com
ISINUS8292141053
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
ObesityHealth DiagnosticsMachine LearningPredictive AnalyticsArtificial IntelligenceBiomedical EngineeringSimulationConsultingImpact InvestingService IndustrySoftware

Description

Simulations Plus, Inc. operates as a developer of modeling and simulation software for drug discovery and development, including the prediction of properties of molecules utilizing artificial intelligence (AI) and machine-learning technologies worldw…

Analysis

Hope premium

Simulations Plus, Inc. carries what we call a hope premium: an average business trading at an ambitious price.

Valuation data is not available for this company.

The trajectory is tepid and the balance sheet is adequate. The company scores 8/20 on our value-creation score: creating some value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
55
2023202420252026

All-time high

94

Jan 2023

All-time low

55

Mar 2026

Average rank

67

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
32
39
7
5
Price/Earnings
38
13
26
24
Price/Book
40
6
49
51
Dividend Yield
1
81
85
80
Value (overall)
28
39
50
47

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Simulations Plus with its peers
Certara
NSQ:CERT
45
CountryUSA
IndustryHealth Care Technology
SizeMedium
Full Stock Analysis →
Schrödinger
NSQ:SDGR
14
CountryUSA
IndustryHealth Care Technology
SizeMedium
Full Stock Analysis →
TG Therapeutics
NAQ:TGTX
77
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
ClearPoint Neuro
NAQ:CLPT
18
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Veeva Systems
NYQ:VEEV
90
CountryUSA
IndustryHealth Care Technology
SizeX-Large
Full Stock Analysis →
Globalstar
NSQ:GSAT
29
CountryUSA
IndustryDiversified Telecommunication Services
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →